Skip to main content
. 2020 Oct 29;11:517672. doi: 10.3389/fphar.2020.517672

TABLE 2.

Adverse events due to pazopanib.

Toxicity All grades (%) Grade ≥3
Fatigue 11 (37.9%)
Hand-foot syndrome 10 (34.5%) 2 (6.9%)
Hair color change 10 (34.5%)
Raised ALT/AST 10 (34.5%)
Hypertension 7 (24.1%)
Neutropenia 3 (10.3%)
Anemia 3 (10.3%)
Thrombocytopenia 2 (6.9%) 1 (3.4%)
Diarrhea 1 (3.4%)